Galectin-3 and plasma cytokines in patients with acute myocardial infarction
View/ Open
Access
info:eu-repo/semantics/openAccessDate
2014Author
Alturfan, Ahmet AtaBaşar, Işık
Emekli-Alturfan, Ebru
Ayan, Faruk
Koldaş, Lale
Emekli, Nesrin
Metadata
Show full item recordCitation
Alturfan, A. A., Başar, I., Emekli-Alturfan, E., Ayan, F., Koldaş, L. ve Emekli, N. (2014). Galectin-3 and plasma cytokines in patients with acute myocardial infarction. Labmedicine, 45(4), 332-337. https://dx.doi.org/10.1309/LM3JZKBDA7D4QFOCAbstract
Objective: To investigate the concentrations of plasma cytokines and Galectin-3 (Gal-3) as inflammatory markers in patients with acute myocardial infarction (AMI). Methods: The study population consisted of 29 patients with AMI and 29 healthy control subjects. We measured Gal-3, tumor necrosis factor alpha (TNF-alpha), and interleukin-6 (IL-6) levels in plasma using enzyme-linked immunosorbent assays (ELISAs). We measured levels of C-reactive protein (CRP) via the nephelometric method. Results: Patients with AMI showed significantly higher plasma Gal-3, TNF-alpha, and IL-6 levels compared with controls. Gal-3 levels were positively and significantly correlated with plasma IL-6, TNF-alpha, and CRP levels in the control and patient groups. Conclusion: Our findings suggest that Gal-3 can be a new circulating biomarker of inflammation associated with AMI.
WoS Q Kategorisi
Q4Source
LabmedicineVolume
45Issue
4Collections
- Makale Koleksiyonu [3642]
- PubMed İndeksli Yayınlar Koleksiyonu [4039]
- Scopus İndeksli Yayınlar Koleksiyonu [6274]
- WoS İndeksli Yayınlar Koleksiyonu [6417]